Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement 2023-07-25 19:30
Foresee Pharmaceuticals Selected for Late-Breaking Oral Presentation on its Aderamastat Phase 2 Study Results at the European Respiratory Society (ERS) International Congress 2023 2023-07-25 15:19
Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial 2023-07-24 21:02
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference 2023-07-22 17:50
Medlinker's MedGPT Performs 96% As Well As Top Human Doctors 2023-07-22 12:30
YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023 2023-07-22 04:30
Mabwell Announces the NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND 2023-07-22 00:00
SunHo Announces First Patient Dosed in Phase I/II Clinical Trial of a Potential First-in-class Immunocytokine IBB0979 2023-07-21 22:51
GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent 2023-07-21 16:47
Jacobio Pharma to Present Data of Glecirasib in Combination with JAB-3312 at the 2023 ESMO Conference 2023-07-21 10:19
US FDA Grants Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer 2023-07-21 08:15
Angel Yeast Highlights Sustainable Protein and Natural Taste Solutions at IFT FIRST 2023 2023-07-20 20:00
BioCity announces the first patient dosed with its first-in-class CDH3-targeting ADC BC3195 in a Phase 1 Trial 2023-07-20 10:41
Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech 2023-07-20 09:01
Origin Agritech Secures RMB 2 Million Grant for Building Germplasm Bank in Xinjiang 2023-07-19 23:54
VARON Launches the Game-changer in the Field--New VP Series Portable Oxygen Concentrator with Increased Mobility and Convenience 2023-07-19 22:30
JX Luxventure announces a new Artificial Intelligence initiative: USD1,000,000 Agreement with Tianjin Baixing Pharmaceutical Wholesale Co., Ltd. in connection with incorporating ChatGPT type technology for ERP platform 2023-07-19 21:36
Kintor Pharma Announces Completion of First Patient Enrollment in Long-term Safety Phase III Trial of KX-826 for Treatment of AGA 2023-07-19 21:03
Yikaida CAR-T Cell Therapy Approved as a Second-line Therapy for New Indication 2023-07-19 10:42
Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND 2023-07-19 00:00
1 85 86 87 88 89 812